Phoenix Spree Deutschland Limited Publication of Prospectus and Circular (5502O)
09 Febbraio 2016 - 3:10PM
UK Regulatory
TIDMPSDL
RNS Number : 5502O
Phoenix Spree Deutschland Limited
09 February 2016
9 February 2016
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN
PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF
AMERICA, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA,
OR ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A
VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH
JURISDICTION.
Phoenix Spree Deutschland Limited
(the "Company")
Publication of Prospectus and Circular
The prospectus of the Company dated 9 February 2016 (the
"Prospectus") relating to the proposed Firm Placing, Offer for
Subscription and Placing Programme (the "Proposals") announced
earlier today has been approved by the Financial Conduct Authority
and has been published. The Company has also sent a circular to its
Shareholders today in relation to the Proposals (the
"Circular").
Copies of the Prospectus and the Circular will be available for
inspection during normal business hours on any weekday (public
holidays excepted) at the registered office of the Company at 13-14
Esplanade, St Helier, Jersey JE1 1BD and by requesting a hard copy
through Appleby Fund Administrators (Jersey) Limited on +44 (0)
1534 818 433. Copies will also be available on the Company's
website www.phoenixspree.com and will shortly be submitted to the
National Storage Mechanism which can be accessed at
http://www.morningstar.co.uk/uk/NSM.
For further information please contact:
PMM Partners UK Limited (Property Advisor) +44 (0) 20 7292 7153
Mike Hilton
Matthew Northover
Paul Ruddle
Stuart Young
Liberum Capital Limited (Sponsor and Bookrunner) +44 (0) 20 3100 2222
Shane Le Prevost
Richard Crawley
Christopher Britton
Jill Li
Bell Pottinger (Financial Public Relations) +44 (0) 20 3772 2500
Nick Lambert
Victoria Geoghegan
Elizabeth Snow
IMPORTANT INFORMATION
Terms defined in the Prospectus have the same meaning when used
in this announcement, unless the context requires otherwise.
Liberum Capital Limited ("Liberum"), which is authorised and
regulated in the United Kingdom by the FCA, is acting exclusively
for the Company and for no-one else in connection with any
Admission and the Issues and the other transactions and
arrangements referred to in this announcement and is not acting
for, nor will it be responsible to any other person (whether or not
a recipient of this announcement) in connection with, any Admission
and the Issues including for providing the protections afforded to
clients of Liberum or for providing advice in connection with any
Admission, the Issues, the contents of this announcement or any
transaction, arrangement or other matter referred to in this
announcement. Liberum is not responsible for the contents of this
announcement. Liberum has not authorised the contents of, or any
part of, this announcement and no liability whatsoever is accepted
by Liberum nor does it make any representation or warranty, express
or implied, for the accuracy of any information or opinion
contained in this announcement or for the omission of any
information. Liberum disclaims all and any responsibility or
liability whether arising in tort, contract or otherwise which it
might otherwise have in respect of this announcement. This does not
exclude or limit any responsibilities which Liberum may have under
FSMA or the regulatory regime established thereunder.
The distribution of this announcement and other documents and/or
information in connection with any Admission and the Issues in
other jurisdictions may be restricted by law and therefore neither
this announcement nor any other documents and/or information in
connection with any Admission and the Issues may be published,
distributed or transmitted by any means or media directly or
indirectly, in whole or in part in or into any jurisdiction except
under circumstances that will result in compliance with any
applicable laws and regulations. Persons into whose possession any
document and/or other information referred to herein comes should
inform themselves about and observe any such restrictions. Any
failure to comply with these restrictions may constitute a
violation of the securities laws of any such jurisdictions. This
announcement does not constitute an offer to sell or the
solicitation of an offer to buy securities in any jurisdiction in
which such offer would be unlawful. In particular, this
announcement does not constitute an offer to buy securities, and it
is not for distribution, directly or indirectly, in or into the
United States of America, Canada, Australia, the Republic of South
Africa, or Japan.
The information contained in this announcement does not
constitute an offering of securities for sale in the United States.
The Shares have not been, and will not be, registered under the
United States Securities Act 1933 (as amended) nor under the
securities laws or with any securities regulatory authority of any
state or other jurisdiction of the United States of America or of
any province or territory of Canada, Australia, the Republic of
South Africa or Japan, nor in any country or territory where to do
so may contravene local securities laws or regulations and will not
be made to any national, resident or citizen of the United States
of America, Canada, Australia, the Republic of South Africa or
Japan. In addition, the Company has not been, and will not be,
registered under the United States Investment Company 1940 (as
amended).
Neither the content of the Company's website nor any website
accessible by hyperlinks on the Company's website is incorporated
in, or forms part of, this announcement.
This information is provided by RNS
The company news service from the London Stock Exchange
END
PDIUGUWUPUPQGCB
(END) Dow Jones Newswires
February 09, 2016 09:10 ET (14:10 GMT)
Grafico Azioni Phoenix Spree Deutschland (LSE:PSDL)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Phoenix Spree Deutschland (LSE:PSDL)
Storico
Da Lug 2023 a Lug 2024